Review



primary human bronchial epithelial cells hbepc  (PromoCell)


Bioz Verified Symbol PromoCell is a verified supplier
Bioz Manufacturer Symbol PromoCell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    PromoCell primary human bronchial epithelial cells hbepc
    Primary Human Bronchial Epithelial Cells Hbepc, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 123 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human bronchial epithelial cells hbepc/product/PromoCell
    Average 95 stars, based on 123 article reviews
    primary human bronchial epithelial cells hbepc - by Bioz Stars, 2026-02
    95/100 stars

    Images



    Similar Products

    99
    ATCC normal human bronchial epithelial cells hbepc
    Normal Human Bronchial Epithelial Cells Hbepc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/normal human bronchial epithelial cells hbepc/product/ATCC
    Average 99 stars, based on 1 article reviews
    normal human bronchial epithelial cells hbepc - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    95
    PromoCell primary human bronchial epithelial cells hbepc
    Primary Human Bronchial Epithelial Cells Hbepc, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human bronchial epithelial cells hbepc/product/PromoCell
    Average 95 stars, based on 1 article reviews
    primary human bronchial epithelial cells hbepc - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    95
    PromoCell primary human bronchial epithelial cells phbecs
    Primary Human Bronchial Epithelial Cells Phbecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human bronchial epithelial cells phbecs/product/PromoCell
    Average 95 stars, based on 1 article reviews
    primary human bronchial epithelial cells phbecs - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    95
    PromoCell human bronchial epithelial cells
    Human Bronchial Epithelial Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bronchial epithelial cells/product/PromoCell
    Average 95 stars, based on 1 article reviews
    human bronchial epithelial cells - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    95
    PromoCell hbepc cells
    Metabolic reprogramming in host cells after PA14 BMV treatment. A) Confluence of A549 and HCC44 cells after treatment with 25 VL/mL BMVs for 72 h. Data were obtained from three replicates. B) Glucose uptake and lactate secretion of A549, HCC44, and <t>HBEpC</t> <t>cells</t> after treatment with 25 VL/mL BMVs for 24 h. Data were obtained from three replicates. C) Signal intensities (AU) of malate, aspartate, and glutamate in A549 and HBEpC cells after vesicle treatment (25 VL/mL for 24 h). Data were obtained from 5 to 6 (A549) or 2 to 3 (HBEpC) replicates and normalized to cell confluence. D) Schematic overview of the incorporation of a [U- 13 C 6 ]-glucose tracer into metabolites of the TCA cycle. Created with BioRender.com . E) Malate MIDs after [U- 13 C 6 ]-glucose labeling of BMV-treated cells. A549 and HCC44 cells were treated for 24 h and HBEpC cells for 6 h with 25 VL/mL. Data were obtained from two or three replicates. F) Schematic overview of the incorporation of a [U- 13 C 5 ]-glutamine tracer into metabolites of the TCA cycle. Created with BioRender.com . G) Malate MIDs after [U- 13 C 5 ]-glutamine labeling of BMV-treated cells. A549 and HCC44 cells were treated for 24 h and HBEpC cells for 6 h with 25 VL/mL. Data were obtained from three replicates. All bar plots in this figure are depicted as mean ± SEM. For the comparison between control (Ctrl) and BMV-treated cells for each cell line, statistical significance was analyzed using unpaired t test (n.s. = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001).
    Hbepc Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hbepc cells/product/PromoCell
    Average 95 stars, based on 1 article reviews
    hbepc cells - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    95
    PromoCell hbepc
    Metabolic reprogramming in host cells after PA14 BMV treatment. A) Confluence of A549 and HCC44 cells after treatment with 25 VL/mL BMVs for 72 h. Data were obtained from three replicates. B) Glucose uptake and lactate secretion of A549, HCC44, and <t>HBEpC</t> <t>cells</t> after treatment with 25 VL/mL BMVs for 24 h. Data were obtained from three replicates. C) Signal intensities (AU) of malate, aspartate, and glutamate in A549 and HBEpC cells after vesicle treatment (25 VL/mL for 24 h). Data were obtained from 5 to 6 (A549) or 2 to 3 (HBEpC) replicates and normalized to cell confluence. D) Schematic overview of the incorporation of a [U- 13 C 6 ]-glucose tracer into metabolites of the TCA cycle. Created with BioRender.com . E) Malate MIDs after [U- 13 C 6 ]-glucose labeling of BMV-treated cells. A549 and HCC44 cells were treated for 24 h and HBEpC cells for 6 h with 25 VL/mL. Data were obtained from two or three replicates. F) Schematic overview of the incorporation of a [U- 13 C 5 ]-glutamine tracer into metabolites of the TCA cycle. Created with BioRender.com . G) Malate MIDs after [U- 13 C 5 ]-glutamine labeling of BMV-treated cells. A549 and HCC44 cells were treated for 24 h and HBEpC cells for 6 h with 25 VL/mL. Data were obtained from three replicates. All bar plots in this figure are depicted as mean ± SEM. For the comparison between control (Ctrl) and BMV-treated cells for each cell line, statistical significance was analyzed using unpaired t test (n.s. = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001).
    Hbepc, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hbepc/product/PromoCell
    Average 95 stars, based on 1 article reviews
    hbepc - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    95
    PromoCell bronchial ecs
    Metabolic reprogramming in host cells after PA14 BMV treatment. A) Confluence of A549 and HCC44 cells after treatment with 25 VL/mL BMVs for 72 h. Data were obtained from three replicates. B) Glucose uptake and lactate secretion of A549, HCC44, and <t>HBEpC</t> <t>cells</t> after treatment with 25 VL/mL BMVs for 24 h. Data were obtained from three replicates. C) Signal intensities (AU) of malate, aspartate, and glutamate in A549 and HBEpC cells after vesicle treatment (25 VL/mL for 24 h). Data were obtained from 5 to 6 (A549) or 2 to 3 (HBEpC) replicates and normalized to cell confluence. D) Schematic overview of the incorporation of a [U- 13 C 6 ]-glucose tracer into metabolites of the TCA cycle. Created with BioRender.com . E) Malate MIDs after [U- 13 C 6 ]-glucose labeling of BMV-treated cells. A549 and HCC44 cells were treated for 24 h and HBEpC cells for 6 h with 25 VL/mL. Data were obtained from two or three replicates. F) Schematic overview of the incorporation of a [U- 13 C 5 ]-glutamine tracer into metabolites of the TCA cycle. Created with BioRender.com . G) Malate MIDs after [U- 13 C 5 ]-glutamine labeling of BMV-treated cells. A549 and HCC44 cells were treated for 24 h and HBEpC cells for 6 h with 25 VL/mL. Data were obtained from three replicates. All bar plots in this figure are depicted as mean ± SEM. For the comparison between control (Ctrl) and BMV-treated cells for each cell line, statistical significance was analyzed using unpaired t test (n.s. = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001).
    Bronchial Ecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bronchial ecs/product/PromoCell
    Average 95 stars, based on 1 article reviews
    bronchial ecs - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    Image Search Results


    Metabolic reprogramming in host cells after PA14 BMV treatment. A) Confluence of A549 and HCC44 cells after treatment with 25 VL/mL BMVs for 72 h. Data were obtained from three replicates. B) Glucose uptake and lactate secretion of A549, HCC44, and HBEpC cells after treatment with 25 VL/mL BMVs for 24 h. Data were obtained from three replicates. C) Signal intensities (AU) of malate, aspartate, and glutamate in A549 and HBEpC cells after vesicle treatment (25 VL/mL for 24 h). Data were obtained from 5 to 6 (A549) or 2 to 3 (HBEpC) replicates and normalized to cell confluence. D) Schematic overview of the incorporation of a [U- 13 C 6 ]-glucose tracer into metabolites of the TCA cycle. Created with BioRender.com . E) Malate MIDs after [U- 13 C 6 ]-glucose labeling of BMV-treated cells. A549 and HCC44 cells were treated for 24 h and HBEpC cells for 6 h with 25 VL/mL. Data were obtained from two or three replicates. F) Schematic overview of the incorporation of a [U- 13 C 5 ]-glutamine tracer into metabolites of the TCA cycle. Created with BioRender.com . G) Malate MIDs after [U- 13 C 5 ]-glutamine labeling of BMV-treated cells. A549 and HCC44 cells were treated for 24 h and HBEpC cells for 6 h with 25 VL/mL. Data were obtained from three replicates. All bar plots in this figure are depicted as mean ± SEM. For the comparison between control (Ctrl) and BMV-treated cells for each cell line, statistical significance was analyzed using unpaired t test (n.s. = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001).

    Journal: PNAS Nexus

    Article Title: Bacterial membrane vesicles of Pseudomonas aeruginosa activate adenosine monophosphate-activated protein kinase signaling through inhibition of mitochondrial complex III

    doi: 10.1093/pnasnexus/pgaf248

    Figure Lengend Snippet: Metabolic reprogramming in host cells after PA14 BMV treatment. A) Confluence of A549 and HCC44 cells after treatment with 25 VL/mL BMVs for 72 h. Data were obtained from three replicates. B) Glucose uptake and lactate secretion of A549, HCC44, and HBEpC cells after treatment with 25 VL/mL BMVs for 24 h. Data were obtained from three replicates. C) Signal intensities (AU) of malate, aspartate, and glutamate in A549 and HBEpC cells after vesicle treatment (25 VL/mL for 24 h). Data were obtained from 5 to 6 (A549) or 2 to 3 (HBEpC) replicates and normalized to cell confluence. D) Schematic overview of the incorporation of a [U- 13 C 6 ]-glucose tracer into metabolites of the TCA cycle. Created with BioRender.com . E) Malate MIDs after [U- 13 C 6 ]-glucose labeling of BMV-treated cells. A549 and HCC44 cells were treated for 24 h and HBEpC cells for 6 h with 25 VL/mL. Data were obtained from two or three replicates. F) Schematic overview of the incorporation of a [U- 13 C 5 ]-glutamine tracer into metabolites of the TCA cycle. Created with BioRender.com . G) Malate MIDs after [U- 13 C 5 ]-glutamine labeling of BMV-treated cells. A549 and HCC44 cells were treated for 24 h and HBEpC cells for 6 h with 25 VL/mL. Data were obtained from three replicates. All bar plots in this figure are depicted as mean ± SEM. For the comparison between control (Ctrl) and BMV-treated cells for each cell line, statistical significance was analyzed using unpaired t test (n.s. = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001).

    Article Snippet: HBEpC cells were cultivated in Airway Epithelial Cell Growth Medium supplemented with Growth Medium SupplementMix (PromoCell, C-21060).

    Techniques: Labeling, Comparison, Control

    PA14 BMVs affect transcription and translation of the host cell. A) RNA-sequencing analysis of A549 cells treated with PA14 BMVs (PA) for 24 h. B) Relative gene expression of HMGCR and SREBF2 in A549 cells after treatment with 25 VL/mL BMVs for 24 h. Data were obtained from three replicates. C) IL-8 secretion of A549 and HBEpC cells after BMV treatment (25 VL/mL for 24 h). Data were obtained from three replicates. D) Global protein synthesis of A549 cells after treatment with 50 µg/mL CHX and 25 VL/mL BMVs for 30 min (+30 min pretreatment). Data were obtained from four or five replicates. All bar plots in this figure are depicted as mean ± SEM. Statistical significance was analyzed using unpaired t test (B, C) or using unpaired one-way ANOVA followed by Tukey's multiple comparison test (D) (* P < 0.05, ** P < 0.01, *** P < 0.001).

    Journal: PNAS Nexus

    Article Title: Bacterial membrane vesicles of Pseudomonas aeruginosa activate adenosine monophosphate-activated protein kinase signaling through inhibition of mitochondrial complex III

    doi: 10.1093/pnasnexus/pgaf248

    Figure Lengend Snippet: PA14 BMVs affect transcription and translation of the host cell. A) RNA-sequencing analysis of A549 cells treated with PA14 BMVs (PA) for 24 h. B) Relative gene expression of HMGCR and SREBF2 in A549 cells after treatment with 25 VL/mL BMVs for 24 h. Data were obtained from three replicates. C) IL-8 secretion of A549 and HBEpC cells after BMV treatment (25 VL/mL for 24 h). Data were obtained from three replicates. D) Global protein synthesis of A549 cells after treatment with 50 µg/mL CHX and 25 VL/mL BMVs for 30 min (+30 min pretreatment). Data were obtained from four or five replicates. All bar plots in this figure are depicted as mean ± SEM. Statistical significance was analyzed using unpaired t test (B, C) or using unpaired one-way ANOVA followed by Tukey's multiple comparison test (D) (* P < 0.05, ** P < 0.01, *** P < 0.001).

    Article Snippet: HBEpC cells were cultivated in Airway Epithelial Cell Growth Medium supplemented with Growth Medium SupplementMix (PromoCell, C-21060).

    Techniques: RNA Sequencing, Gene Expression, Comparison

    Activation of AMPK signaling in host cells by PA14 BMVs. A) Overview of the AMPK signaling targets ACC1 and eEF2 and their activation. B) Western blot (WB) analysis of p-ACC1 (Ser79) in A549 cells after vesicle treatment (25 and 50 VL/mL) for 24 h. Data were obtained from two independent experiments. C) WB analysis of p-eEF2 (Thr56) in A549 cells after vesicle treatment (25 and 50 VL/mL) for 24 h. Data were obtained from two independent experiments. D) WB analysis of p-eEF2 (Thr56) in HCC44 cells after vesicle treatment (25 and 50 VL/mL) for 24 h. E) WB analysis of p-eEF2 (Thr56) in HBEpC cells after vesicle treatment (25 and 50 VL/mL) for 24 h. All bar plots in this figure are depicted as mean (±SEM).

    Journal: PNAS Nexus

    Article Title: Bacterial membrane vesicles of Pseudomonas aeruginosa activate adenosine monophosphate-activated protein kinase signaling through inhibition of mitochondrial complex III

    doi: 10.1093/pnasnexus/pgaf248

    Figure Lengend Snippet: Activation of AMPK signaling in host cells by PA14 BMVs. A) Overview of the AMPK signaling targets ACC1 and eEF2 and their activation. B) Western blot (WB) analysis of p-ACC1 (Ser79) in A549 cells after vesicle treatment (25 and 50 VL/mL) for 24 h. Data were obtained from two independent experiments. C) WB analysis of p-eEF2 (Thr56) in A549 cells after vesicle treatment (25 and 50 VL/mL) for 24 h. Data were obtained from two independent experiments. D) WB analysis of p-eEF2 (Thr56) in HCC44 cells after vesicle treatment (25 and 50 VL/mL) for 24 h. E) WB analysis of p-eEF2 (Thr56) in HBEpC cells after vesicle treatment (25 and 50 VL/mL) for 24 h. All bar plots in this figure are depicted as mean (±SEM).

    Article Snippet: HBEpC cells were cultivated in Airway Epithelial Cell Growth Medium supplemented with Growth Medium SupplementMix (PromoCell, C-21060).

    Techniques: Activation Assay, Western Blot